Suchergebnisse - "rucaparib"

PubPharm (164)

1

ADP-ribosyltransferase PARP11 modulates the interferon antiviral response by mono-ADP-ribosylating the ubiquitin E3 ligase β-TrCP

enthalten in: Nature microbiology | 2019

von Guo, T. | Zuo, Y. | Qian, L. | +11

CommentIn: Nat Microbiol. 2019 Nov;4(11):1771-1773. - PMID 31649358

2

Maintenance therapy for recurrent epithelial ovarian cancer : current therapies and future perspectives - a review

enthalten in: Journal of ovarian research | 2019

von Gupta, S. | Nag, S. | Aggarwal, S. | +2

3

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review

enthalten in: Journal of ovarian research | 2019

von Gupta, S. | Nag, S. | Aggarwal, S. | +2

4

Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2019

von Kristeleit, R. | Oaknin, A. | Ray-Coquard, I. | +12

5

Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib

enthalten in: Investigational new drugs | 2019

von Augustine, T. | Maitra, R. | Zhang, J. | +2

6

Activation of Wnt signaling promotes olaparib resistant ovarian cancer

enthalten in: Molecular carcinogenesis | 2019

von Yamamoto, T. | McMellen, A. | Watson, Z. | +13

7

A decade of clinical development of PARP inhibitors in perspective

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Mateo, J. | Lord, C. | Serra, V. | +7

8

Comment on : "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States"

enthalten in: PharmacoEconomics | 2019

von Wallace, K. | Goble, S. | Isaacson, J. | +3

CommentOn: Pharmacoeconomics. 2019 Mar;37(3):391-405. - PMID 30478649

9

A label-free PFP-based photoelectrochemical biosensor for highly sensitive detection of PARP-1 activity

enthalten in: Biosensors & bioelectronics | 2019

von Wang, C. | Li, Y. | Xu, E. | +5

10

Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States"

enthalten in: PharmacoEconomics | 2019

von McQueen, R. | Whittington, M. | Chapman, R. | +2

CommentOn: Pharmacoeconomics. 2019 Mar;37(3):391-405. - PMID 30478649

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]